Profile: Wockhardt Limited provides biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). We are involved in gene cloning, development of production strains, expression of proteins in all major expression systems like yeast, mammalian and bacterial cells and downstream processing & development. We offer wepox which is a recombinant erythropoietin, indicated for the treatment of anaemia caused by cancer & chronic renal failure. Our product wouslin is the first r-DNA insulin developed and manufactured through the latest yeast based expression system.